Cellebrite DI Ltd. CLBT
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | 5.31% | 3.66% | 11.93% | ||
| Total Depreciation and Amortization | 45.80% | 4.28% | -1.48% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 9.74% | 232.70% | -28.61% | ||
| Change in Net Operating Assets | 1,881.69% | -140.25% | 242.15% | ||
| Cash from Operations | 160.91% | 2.11% | 56.06% | ||
| Capital Expenditure | -19.08% | 7.93% | -54.25% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -241.11% | 51.88% | 135.59% | ||
| Cash from Investing | -485.83% | 57.20% | 132.08% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -55.57% | -61.91% | 281.93% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -55.57% | -61.91% | 281.93% | ||
| Foreign Exchange rate Adjustments | 129.63% | -110.73% | 114.36% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -253.62% | 15.09% | 187.71% | ||